Disclosed positions

Estimated from their latest filings — positions may have changed since

$6.12M

combined est. value

Stock	Shares	Price	Value	Weight	As of
COLLCOLLEGIUM PHARMACEUTICAL, INC	107,081	$33.37	$3.57M	58%	2026-05-18
SIBNSI-BONE, Inc.	146,025	$17.42	$2.54M	42%	2026-06-04

COLL

COLLEGIUM PHARMACEUTICAL, INC

$3.57M

107,081 sh

SIBN

SI-BONE, Inc.

$2.54M

146,025 sh

All filings on record

Every Form 4 transaction we track for this filer

all 10buys 0sells 5

Stock	Transaction	Date	~6mo later
SIBNSI-BONE, Inc.	Grant — · 10,957 sh	2026-06-04	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Sell $681.00 · 20 sh	2026-05-18	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Sell $142.5K · 4,127 sh	2026-05-15	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Exercise $143.5K · 8,700 sh	2026-05-15	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Grant — · 8,741 sh	2026-05-14	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Sell $400.6K · 11,659 sh	2025-08-08	—
SIBNSI-BONE, Inc.	Sell $194.0K · 12,132 sh	2025-08-08	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Sell $202.1K · 6,601 sh	2025-06-09	—
COLLCOLLEGIUM PHARMACEUTICAL, INC	Exercise $201.8K · 15,000 sh	2025-06-09	—
SIBNSI-BONE, Inc.	Grant — · 8,675 sh	2025-06-05	—

SIBNGrant

2026-06-04 · SI-BONE, Inc.

10,957

—

COLLSell

2026-05-18 · COLLEGIUM PHARMACEUTICAL, INC

$681.00

—

COLLSell

2026-05-15 · COLLEGIUM PHARMACEUTICAL, INC

$142.5K

—

COLLExercise

2026-05-15 · COLLEGIUM PHARMACEUTICAL, INC

$143.5K

—

COLLGrant

2026-05-14 · COLLEGIUM PHARMACEUTICAL, INC

8,741

—

COLLSell

2025-08-08 · COLLEGIUM PHARMACEUTICAL, INC

$400.6K

—

SIBNSell

2025-08-08 · SI-BONE, Inc.

$194.0K

—

COLLSell

2025-06-09 · COLLEGIUM PHARMACEUTICAL, INC

$202.1K

—

COLLExercise

2025-06-09 · COLLEGIUM PHARMACEUTICAL, INC

$201.8K

—

SIBNGrant

2025-06-05 · SI-BONE, Inc.

8,675

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.